![Mark Redshaw](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Redshaw
Directeur/Bestuurslid bij Vivasure Medical Ltd.
Profiel
Mark Redshaw currently works at Vivasure Medical Ltd., as Director and Evonik Venture Capital GmbH, as Investment Director from 2016.
Actieve functies van Mark Redshaw
Bedrijven | Functie | Begin |
---|---|---|
Evonik Venture Capital GmbH
![]() Evonik Venture Capital GmbH Investment ManagersFinance Evonik Venture Capital GmbH (Evonik Venture Capital) is the venture capital subsidiary of Evonik Operations GmbH, itself a subsidiary of RAG-Stiftung. The firm was founded in 2007 and is headquartered in Hanau, Germany. | Private Equity Investor | 01-08-2012 |
Vivasure Medical Ltd.
![]() Vivasure Medical Ltd. Medical SpecialtiesHealth Technology Vivasure Medical Ltd. manufactures medical devices to enable deployment of vascular implants. It offers an absorbable implant and delivery system for use in a range of medical applications, primarily in minimally invasive and percutaneous procedures, such as percutaneous closure of arteriotomies. The company was founded by Gerard Brett and Christopher Martin on August 27, 2008 and is headquartered in Galway, Ireland. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Evonik Venture Capital GmbH
![]() Evonik Venture Capital GmbH Investment ManagersFinance Evonik Venture Capital GmbH (Evonik Venture Capital) is the venture capital subsidiary of Evonik Operations GmbH, itself a subsidiary of RAG-Stiftung. The firm was founded in 2007 and is headquartered in Hanau, Germany. | Finance |
Vivasure Medical Ltd.
![]() Vivasure Medical Ltd. Medical SpecialtiesHealth Technology Vivasure Medical Ltd. manufactures medical devices to enable deployment of vascular implants. It offers an absorbable implant and delivery system for use in a range of medical applications, primarily in minimally invasive and percutaneous procedures, such as percutaneous closure of arteriotomies. The company was founded by Gerard Brett and Christopher Martin on August 27, 2008 and is headquartered in Galway, Ireland. | Health Technology |